Early Communication Development of Children with Auditory Brainstem Implants

• Published in: Journal of deaf studies and deaf education 2018-07, Vol.23 (3), p.249-260
• Main Authors: Eisenberg, Laurie S, Hammes Ganguly, Dianne, Martinez, Amy S, Fisher, Laurel M, Winter, Margaret E, Glater, Jamie L, Schrader, Debra K, Loggins, Janice, Wilkinson, Eric P
• Format: Article
• Language: English
• Subjects: Empirical Manuscript
• ISSN: 1081-4159; 1465-7325
• DOI: 10.1093/deafed/eny010

Abstract The auditory brainstem implant (ABI) is an auditory sensory device that is surgically placed on the cochlear nucleus of the brainstem for individuals who are deaf but unable to benefit from a cochlear implant (CI) due to anatomical abnormalities of the cochlea and/or eighth nerve, specific disease processes, or temporal bone fractures. In the United States, the Food and Drug Administration has authorized a Phase I clinical trial to determine safety and feasibility of the ABI in up to 10 eligible young children who are deaf and either derived no benefit from the CI or were anatomically unable to receive a CI. In this paper, we describe the study protocol and the children who have enrolled in the study thus far. In addition, we report the scores on speech perception, speech production, and language (spoken and signed) for five children with 1–3 years of assessment post-ABI activation. To date, the results indicate that spoken communication skills are slow to develop and that visual communication remains essential for post-ABI intervention.